Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
1981
Overexpressions of the AB domain of RPA70 and the β-barrel domain of Ku70 significantly decrease HBoV1 replication in HAE-ALI.
Published 2022“…Duplex HBoV1 genome was loaded as a size marker (M) of 5.5 kb. …”
-
1982
-
1983
-
1984
-
1985
-
1986
-
1987
-
1988
-
1989
Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.).
Published 2013“…The increase in EEG amplitude may be interpreted as synchronization and a decrease in EEG can be interpreted as a desynchronization. …”
-
1990
-
1991
The wound healing microenvironment restored GJIC but did not directly decrease tumor cells.
Published 2015“…(B and C) The combination of three compounds led to angiogenesis and optimal fibroblast proliferation but did not directly decrease A549 cancer cells. The results are presented as mean±SE (n = 5/group) **<i>p</i> < 0.01 <i>vs</i> control group.…”
-
1992
SLE T cells display more genes with increased rather than decreased expression.
Published 2015“…<p><b>A)</b> Distribution of expression stratified at the 1.5-, 2-fold and q<0.05 CUFFDIFF2 significance levels. …”
-
1993
-
1994
-
1995
-
1996
-
1997
Socio-demographic and work environment characteristics of participants (n = 165).
Published 2024Subjects: -
1998
-
1999
-
2000
Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-9
Published 2011“…<p><b>Copyright information:</b></p><p>Taken from "Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism"</p><p>http://ccforum.com/content/12/1/R2</p><p>Critical Care 2008;12(1):R2-R2.…”